Systematic review with meta-analysis: incidence of variceal hemorrhage in patients with cirrhosis undergoing transesophageal echocardiography
- PMID: 35343613
- PMCID: PMC9197198
- DOI: 10.1111/apt.16860
Systematic review with meta-analysis: incidence of variceal hemorrhage in patients with cirrhosis undergoing transesophageal echocardiography
Abstract
Background: The presence of esophageal varices is considered a relative contraindication to transesophageal echocardiography (TEE) by cardiology professional societies, so gastroenterologists are often consulted to perform upper endoscopy prior to TEE in patients with cirrhosis.
Aim: To perform a systematic review to quantify the risk of bleeding complications in patients with cirrhosis following TEE.
Methods: Two reviewers searched Ovid MEDLINE, MEDLINE In-Process and EMBASE databases from January 1992 to May 2021 for studies reporting bleeding complications from TEE in patients with cirrhosis. We calculated the pooled incidence rate of bleeding events using the metaprop command with a random effect model.
Results: We identified 21 studies comprising 4050 unique patients with cirrhosis; 9 studies (n = 3015) assessed the risk of intraoperative TEE during liver transplant (LT) and 12 studies (n = 1035) assessed bleeding risk in patients undergoing TEE for other indications. The pooled incidence of bleeding post-TEE was 0.37% (95% CI 0.04-0.94%) across all studies. Bleeding complications were low among patients undergoing TEE during LT as well as those undergoing TEE for other diagnostic reasons (0.97% vs. 0.004%) and among studies with mean MELD >18 compared to those with mean MELD <18 (0.43% vs. 0.08%). Few studies had a comparator arm, and data on patient-level factors impacting bleeding complications (including degree of liver dysfunction and coagulopathy) were limited across studies.
Conclusions: The risk of bleeding complications following TEE is low in patients with cirrhosis, suggesting TEE is safe and risk stratification with upper endoscopy may not be necessary.
Keywords: bleeding; cardiac testing; portal hypertension; risk; varices.
© 2022 John Wiley & Sons Ltd.
Conflict of interest statement
Figures
Comment in
-
Editorial: variceal haemorrhage-under pressure, not the probe pushing down on me.Aliment Pharmacol Ther. 2022 May;55(9):1224-1225. doi: 10.1111/apt.16897. Aliment Pharmacol Ther. 2022. PMID: 35429027 No abstract available.
References
-
- Bambha K, Kim WR, Pedersen R, et al. Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut 2008;57:814–820. - PubMed
-
- Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology 2017;65:310–335. - PubMed
-
- Zaman A, Becker T, Lapidus J, et al. Risk Factors for the Presence of Varices in Cirrhotic Patients Without a History of Variceal Hemorrhage. Archives of Internal Medicine 2001;161:2564–2570. - PubMed
-
- Daniel WG, Erbel R, Kasper W, et al. Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation 1991;83:817–21. - PubMed
-
- Hilberath JN, Oakes DA, Shernan SK, et al. Safety of Transesophageal Echocardiography. Journal of the American Society of Echocardiography 2010;23:1115–1127. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical